Literature DB >> 6597352

The effect of kinins on paw oedema and uterus in rats.

E T Whalley, C A Sampaio, H Fritz, G Edwards.   

Abstract

Bradykinin (BK) produced a dose-related increase in the paw volume of the rat. Responses to BK at all doses used were not affected by pretreating the rats with diphenhydramine, 1 mg kg-1, or indomethacin, 2.5 and 5 mg kg-1. Indomethacin, 10 mg kg-1 produced a small but significant reduction in the responses to BK. Captopril 1 mg kg-1 enhanced responses to low but not to high doses of BK. The rank order of potency of various kinin analogues to increase paw volume was found to be methionyl-lysyl-BK (met-lys-BK) greater than BK greater than lysyl-BK (Kallidin) much greater than des-Arg9-BK. The B1-receptor antagonist des-Arg9-Leu8-BK did not affect responses to BK on paw volume. Two modified kinin fragments S2302 (H-D-Pro-Phe-Arg-p-Nitroaniline) and S2441 (H-D-Pro-Phe-Arg-NH-heptyl) produced dose-related increases in paw volume both having approximately half the potency of BK. These responses were not antagonised by diphenhydramine, 1 mg kg-1 which reduced significantly the response to histamine. On the isolated rat uterus the rank order of potency of various kinins was BK greater than Kallidin greater than met-lys-BK greater than des-Arg9-BK. The two modified kinin fragments S2302 and S2441 (but not des-Arg9-Leu8-BK) antagonised BK induced contractions of the rat uterus. From the rank order of potency studies the receptor mediating contraction of the rat uterus in vitro and increase in rat paw volume to BK appear to be of the same type.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6597352     DOI: 10.1007/bf00512073

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

Review 1.  Captopril (SQ 14,225) (D-3-mercapto-2-methylpropranoyl-L-proline): a novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent.

Authors:  B Rubin; M J Antonaccio; Z P Horovitz
Journal:  Prog Cardiovasc Dis       Date:  1978 Nov-Dec       Impact factor: 8.194

2.  A simple precise method for measuring rodent paw volume.

Authors:  J M Hall; C Hallett
Journal:  J Pharm Pharmacol       Date:  1975-08       Impact factor: 3.765

3.  Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids.

Authors:  D W Cushman; H S Cheung; E F Sabo; M A Ondetti
Journal:  Biochemistry       Date:  1977-12-13       Impact factor: 3.162

Review 4.  Pharmacology of kinins: their relevance to tissue injury and inflammation.

Authors:  F Marceau; A Lussier; D Regoli; J P Giroud
Journal:  Gen Pharmacol       Date:  1983

5.  Antagonism of the bradykinin induced contractile response of isolated smooth muscle preparations by low molecular weight synthetic chromogenic peptide substrates for serine proteases.

Authors:  J Fareed; G Kindel; H L Messmore; J U Balis
Journal:  Adv Biosci       Date:  1978-07-22

6.  Pharmacological characterization of the vascular permeability enhancing effects of kinins in the rabbit skin.

Authors:  F Marceau; M Knap; D Regoli
Journal:  Can J Physiol Pharmacol       Date:  1981-09       Impact factor: 2.273

Review 7.  Pharmacology of bradykinin and related kinins.

Authors:  D Regoli; J Barabé
Journal:  Pharmacol Rev       Date:  1980-03       Impact factor: 25.468

8.  Receptors for bradykinin in intestinal and uterine smooth muscle.

Authors:  J Brabé; J N Drouin; D Regoli; W K Park
Journal:  Can J Physiol Pharmacol       Date:  1977-12       Impact factor: 2.273

9.  The action of bradykinin and oxytocin on the isolated whole uterus and myometrium of the rat in oestrus.

Authors:  E T Whalley
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

10.  Inhibition of the contractile action of bradykinin on isolated smooth muscle preparations by derivatives of low molecular weight peptides.

Authors:  G Claeson; J Fareed; C Larsson; G Kindel; S Arielly; R Simonsson; H L Messmore; J U Balis
Journal:  Adv Exp Med Biol       Date:  1979       Impact factor: 2.622

View more
  6 in total

1.  Potentiation of the pro-inflammatory effects of bradykinin by inhibition of angiotensin-converting enzyme and aminopeptidase P in rat paws.

Authors:  J Damas; J F Liégeois; W H Simmons
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

2.  New synthetic antagonists of bradykinin.

Authors:  M Schachter; Y Uchida; D J Longridge; T Labedz; E T Whalley; R J Vavrek; J M Stewart
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

3.  Effect of a crude extract of Mandevilla velutina on contractions induced by bradykinin and [des-Arg9]-bradykinin in isolated vessels of the rabbit.

Authors:  J B Calixto; R A Yunes
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

4.  Analysis of the receptors mediating vascular actions of bradykinin.

Authors:  E T Whalley; I A Nwator; J M Stewart; R J Vavrek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

5.  Receptors mediating the increase in vascular permeability to kinins: comparative studies in rat, guinea-pig and rabbit.

Authors:  E T Whalley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

6.  The effect of kinin agonists and antagonists on the pain response of the human blister base.

Authors:  E T Whalley; S Clegg; J M Stewart; R J Vavrek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.